Skip to main content

Table 2 Median cost of HBV-related care across healthcare facilities in Ghana

From: A nationwide cross-sectional review of in-hospital hepatitis B virus testing and disease burden estimation in Ghana, 2016 - 2021

 

Subsidized price with government health insurance

USD Equivalenta

Median (Range)

Non-subsidized price without government health insurance

USD Equivalenta

Median (Range)

Diagnostics

 HBsAg

0.89 (0 – 1.94)

2.91 (0.56 – 5.00)

 HBV Profile

3.15 (1.96 – 8.07))

7.26 (5.65 – 50.03)

 HBV DNA

Not subsidized

64.56 (48.42 – 67.79)

 Liver Function

3.23 (0 - 6.46)

9.68 (8.07 – 12.91)

 APRI

4.23 (0 – 9.68)

13.71 (2.42 – 16.14)

 INR

Not subsidized

8.47 (3.23 – 9.68)

 Ultrasound

3.39 (0 – 4.84)

8.88 (6.46 – 19.34)

 Abdominal CT

Not subsidized

137.20 (87.16 – 187.22)

 Endoscopy

Not subsidized

44.39 (32.28 – 64.56)

 Biopsy

Not subsidized

64.56 (48.42 – 80.7)

Therapeutic

 Annual cost of tenofovir

Not subsidized

260.50 (145.26 – 290.52)

  1. a1 GHS = USD 0.1614 at the time of data collection